Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Starpharma Holdings Ltd.

www.starpharma.com

Latest From Starpharma Holdings Ltd.

Signs Of Life In The Bacterial Vaginosis, Vulvovaginal Candidiasis Pipeline

Scynexis highlights enrollment exceeding expectations in Phase III VVC trials; Daré prepares to enter Phase III to treat BV.

Deal Watch: Sanofi Further Opts Out Of CNS Tie-Up With Voyager

Sanofi returns two partnered assets to Voyager, further unraveling 2015 deal. Celgene drops Mereo cancer candidate ahead of merger with Bristol, while Ultragenyx and Arcturus expand their joint rare disease efforts.

Business Strategies Commercial

Keeping Track: US FDA Approves Esperoct, Tightens Chantix Label, Starts Review Of Alder’s CGRP Candidate

The latest drug development news and highlights from our US FDA Performance Tracker.
Drug Review Approvals

2018 Complete Response Letters: Efficacy Issues Drove Most Product Rejections

US FDA issued at least seven rejections to novel products; opioid analgesic sponsors had very little success, while biosimilar developers had a so-so year.

Complete Response Letters Drug Review
See All

Company Information

  • Industry
  • Biotechnology
    • Large Molecule
    • Nanotechnology, Chips, etc.
  • In Vitro Diagnostics
  • Pharmaceuticals
    • Drug Delivery
      • Macromolecule
      • Topical Delivery
    • Radiopharmaceuticals, Contrast Agents
  • Research, Analytical Equipment & Supplies
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Starpharma Group
  • Starpharma Pooled Development Ltd.
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Australia
  • Parent & Subsidiaries
  • Starpharma Holdings Ltd.
  • Senior Management
  • Jackie Fairley, CEO
    Nigel Baade, CFO
    Tony Eglezos, PhD, VP, Bus. Dev.
    David Owen, PhD, VP, Research
    Jeremy Paull, VP, Dev. & Reg. Affairs
  • Contact Info
  • Starpharma Holdings Ltd.
    Phone: (61) 3 8532 2700
    4-6 Southampton Cresent
    Abbotsford, 3067
    Australia
Advertisement
Advertisement
UsernamePublicRestriction

Register